首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1458169

全球蛋白質工程市場規模、佔有率和成長分析：按產品、技術、蛋白質類型和最終用戶 - 產業預測（2024-2031）

Global Protein Engineering Market Size, Share, Growth Analysis, By Product, By Technology, By Protein Type, By End-User - Industry Forecast 2024-2031

出版日期: 2024年03月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球蛋白質工程市場規模將為21.6億美元，預測期間（2024-2031年）複合年成長率為16.60%，從2023年的25.2億美元預計成長至86億美元。

生物技術和製藥行業越來越關注推進基於蛋白質的治療方法，理由是它們相對於非蛋白質藥物的成本效益和患者結果。這種轉變是由對標靶治療的需求不斷成長所推動的，特別是針對癌症和自體免疫疾病等病理，這推動了蛋白質工程技術的採用。 COVID-19 大流行進一步加速了這一趨勢，蛋白質工程發揮關鍵作用，特別是在疫苗和診斷的開發中。例如，2021年7月，德國埃因霍溫理工大學的科學家設計了一種生物發光診斷試劑套件來檢測冠狀病毒抗體，凸顯了此類創新的實用化。隨著探索基於蛋白質的 COVID-19 及其他治療方法的臨床試驗的增加，以及政府支持和資金的增加，蛋白質工程市場有望大幅擴張。產業相關人員之間的合作，例如Generate Biomedicines和Amgen之間的合作夥伴關係，以及人們對蛋白質工程解決方案在解決慢性疾病和營養不良問題（特別是在服務不足的社區）方面日益成長的認知和需求，正在推動這一趨勢向前發展。隨著合成生物學和個人化治療等領域的持續投資和進步，蛋白質工程產業在可預見的未來前景樂觀。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
Genscript Biotech Corporation
Codexis, Inc.
Danaher Corporation
Bio-Rad Laboratories, Inc.
Bruker Corporation
PerkinElmer, Inc.
Creative Biomart
Abcam plc
Enzyme by Design Ltd.
Twist Bioscience Corporation
GenScript Biotech Corporation
Cyrus Biotechnology, Inc.
Integrated DNA Technologies, Inc.（IDT）
New England Biolabs
Genentech, Inc.
Promega Corporation
Sutro Biopharma, Inc.

簡介目錄

Product Code: SQMIG35H2172

Global Protein Engineering Market size was valued at USD 2.16 Billion in 2022 and is poised to grow from USD 2.52 Billion in 2023 to USD 8.6 Billion by 2031, at a CAGR of 16.60% during the forecast period (2024-2031).

Biotechnology and pharmaceutical sectors are increasingly directing their focus towards the advancement of protein-based therapies, citing their superiority over non-protein drugs in terms of cost-effectiveness and patient outcomes. This shift is particularly fueled by a rising demand for targeted treatments to combat conditions such as cancer and autoimmune diseases, propelling the adoption of protein engineering techniques. The COVID-19 pandemic has further catalyzed this trend, notably in the development of vaccines and diagnostics, where protein engineering has played a pivotal role. For instance, in July 2021, scientists at Eindhoven University of Technology in Germany devised a bioluminescent diagnostic kit to detect coronavirus antibodies, highlighting the practical applications of such innovations. With an uptick in clinical trials exploring protein-based treatments for COVID-19 and beyond, coupled with increased governmental support and funding, the protein engineering market is poised for significant expansion. Collaborations between industry players, such as the partnership between Generate Biomedicines and Amgen, and the growing awareness and need for protein engineering solutions in addressing chronic diseases and malnutrition, particularly in underserved regions, further underscore the sector's potential for growth. With ongoing investments and advancements, including in areas like synthetic biology and personalized therapy, the outlook for the protein engineering industry appears promising for the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Protein Engineering Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Protein Engineering Market Segmental Analysis

The global protein engineering market is segmented based on technology, protein type, product, end user, and region. In terms of product, the market is segmented into instruments, reagents, and software & services. With respect to segmentation by technology, the market is widespread into rational protein design, directed evolution, hybrid approach, de novo protein design, and others. Based on protein type, the market is grouped into insulin, monoclonal antibodies, vaccines, growth factors, colony stimulating factors, coagulation factors, interferon, and others. By end-use, the market is segmented into academic research institutes, contract research organizations, and pharmaceutical & biotechnology companies. Region wise, the market is widespread into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Protein Engineering Market

Protein engineering is pivotal in advancing therapeutic proteins like antibodies, enzymes, and hormones, vital in combating chronic illnesses and meeting the escalating demand for precise and tailored treatments. The surge in chronic diseases and the call for personalized therapies underscore the necessity for innovative and enhanced therapeutic proteins.

Restraints in the Global Protein Engineering Market

Protein engineering necessitates substantial investment in research and development endeavors, encompassing procurement of laboratory equipment, specialized skill sets, and undertaking clinical trials. The considerable expenses tied to these pursuits can pose a significant barrier, particularly for small to medium-sized enterprises.

Market Trends of the Global Protein Engineering Market

The increasing desire for personalized medicine involves tailoring treatments to individual patients according to their genetic composition. Through protein engineering, there's a capacity to craft personalized therapeutic proteins and antibodies, precisely targeting particular ailments and enhancing patient prognoses.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Protein Engineering Market by Product

Market Overview
Instruments
Reagents
and Software & Services

Global Protein Engineering Market by Technology

Market Overview
Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
and Others

Global Protein Engineering Market by Protein Type

Market Overview
Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
and Others

Global Protein Engineering Market by End-User

Market Overview
Academic Research Institutes
Contract Research Organizations
and Pharmaceutical & Biotechnology Companies

Global Protein Engineering Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biomart
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzyme by Design Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyrus Biotechnology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (IDT)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sutro Biopharma, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments